Response to COVID-19 boosters in seronegative multiple sclerosis patients - News-Medical.Net

Researchers report humoral T-cell responses in seronegative MS patients after receiving a third COVID-19 booster vaccine dose.

As of March 21, 2022, the coronavirus 2019 (COVID-19) has claimed the lives of almost 6.1 million globally. Vaccines have played a significant role in reducing overall COVID-19-related morbidity and … [+4749 chars]

full article...